{"gene":"NTRK2","run_date":"2026-06-10T05:19:52","timeline":{"discoveries":[{"year":1989,"finding":"trkB encodes a novel glycoprotein receptor tyrosine kinase (gp145trkB) with a 145 kDa molecular weight (93 kDa polypeptide backbone), expressed preferentially in brain and nervous system tissues, identifying it as a cell surface receptor in the tyrosine kinase family.","method":"cDNA cloning, glycoprotein synthesis from biologically active cDNA, in situ hybridization","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — original biochemical characterization with cDNA reconstitution, molecular weight determination, and expression analysis; foundational paper replicated extensively","pmids":["2555172"],"is_preprint":false},{"year":1992,"finding":"The trkB tyrosine kinase receptor serves as a functional receptor for neurotrophin-4 (NT-4/XNT-4): XNT-4 displaces 125I-BDNF from gp145trkB, induces tyrosine phosphorylation, causes NIH 3T3 transformation when co-expressed with gp145trkB, and induces PC12 neuronal differentiation. Mutation of extracellular Cys-345 to Ser abolishes XNT-4 activation but not BDNF activation, indicating partially distinct binding domains for NT-4 and BDNF on TrkB.","method":"Radioligand displacement assay (125I-BDNF), tyrosine phosphorylation assay, NIH 3T3 transformation assay, PC12 differentiation assay, site-directed mutagenesis (Cys345Ser)","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal in vitro assays plus mutagenesis identifying distinct ligand contact residues in a single study","pmids":["1375038"],"is_preprint":false},{"year":1994,"finding":"In neuroblastoma cells (SMS-KCN) co-expressing TrkB and BDNF, exogenous BDNF induces tyrosine phosphorylation of TrkB and activates downstream phospholipase C-γ1, ERK1/2, and PI3K; BDNF also induces immediate-early genes c-FOS and NGFI-A and promotes cell survival and neurite outgrowth, constituting an autocrine/paracrine survival loop.","method":"Tyrosine phosphorylation assay (immunoblot), downstream kinase activation assays, immediate-early gene expression, cell survival and neurite outgrowth assays","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple downstream signaling readouts in a cell line with BDNF stimulation; single lab","pmids":["8264643"],"is_preprint":false},{"year":1996,"finding":"Non-catalytic (truncated) TrkB isoforms act as dominant-negative receptors: co-expression of non-catalytic TrkB with catalytic TrkB in NGF-dependent sympathetic neurons substantially reduces BDNF-mediated survival signaling, demonstrating that the relative levels of catalytic vs. non-catalytic TrkB isoforms modulate BDNF responsiveness.","method":"Plasmid injection into neurons, survival assay, manipulation of TrkB isoform expression ratios","journal":"The EMBO journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct functional assay in primary neurons with isoform co-expression; single lab","pmids":["8978665"],"is_preprint":false},{"year":1998,"finding":"TrkB is required for maturation and synaptogenesis of hippocampal connections in vivo: trkB(-/-) mice show reduced axon collaterals (21-49%), decreased axonal varicosity density, lower synaptic contact density, altered presynaptic bouton ultrastructure (decreased synaptic vesicle density), and reduced expression of v-SNARE and t-SNARE synaptic proteins, demonstrating TrkB is essential for presynaptic development.","method":"Lipophilic tracer injections, biocytin fills, electron microscopy, immunocytochemistry, knockout mouse analysis","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (tract tracing, EM, immunocytochemistry) in genetic knockout mice","pmids":["9736654"],"is_preprint":false},{"year":2002,"finding":"TrkB mediates hippocampal LTP via recruitment of PLCγ and subsequent phosphorylation of CaMKIV and CREB: mice with targeted mutation in the PLCγ docking site of TrkB (trkB(PLC/PLC)) show impaired hippocampal LTP and strongly reduced CaMKIV/CREB phosphorylation upon BDNF stimulation, while MAPK activation is retained. Mice with mutated Shc docking site (trkB(SHC/SHC)) retain LTP but show impaired MAPK activation, indicating parallel signaling pathways.","method":"Targeted knockin mutagenesis (PLCγ and Shc docking site mutations), electrophysiology (LTP recording), BDNF-stimulated signaling assays (pCaMKIV, pCREB, pMAPK) in primary neurons","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 1 / Strong — genetic knockin mutagenesis combined with electrophysiology and biochemical signaling assays; widely replicated/cited","pmids":["12367511"],"is_preprint":false},{"year":2004,"finding":"TrkB suppresses anoikis (detachment-induced apoptosis) in non-malignant epithelial cells by activating the PI3K/PKB (Akt) pathway, enabling cell survival and proliferation in suspension and promoting metastasis in mice. TrkB-expressing cells formed rapidly growing tumors that infiltrated lymphatics and blood vessels.","method":"Genome-wide functional screen for anoikis suppression, PI3K/Akt pathway inhibition assays, mouse tumor formation and metastasis assays","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — functional screen plus defined pathway (PI3K/Akt) plus in vivo metastasis model; published in high-impact journal with extensive replication","pmids":["15329723"],"is_preprint":false},{"year":2009,"finding":"NTRK2 (TrkB) and NTRK1 receptors are required for timely primordial follicle assembly and early follicular development in the mouse ovary; Ntrk2(-/-) mice show reduced follicle assembly and decreased FSH receptor (FSHR) expression. NT-4 (NTF4) exposure increases Fshr gene expression and cyclin D2 formation, indicating TrkB signaling induces functional FSHR to facilitate subsequent follicle development.","method":"Knockout mouse analysis (Ntrk2(-/-)), follicle counting, FSHR expression assay, NTF4 treatment of ovaries, cyclin D2 formation assay","journal":"Reproduction (Cambridge, England)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic knockout with multiple readouts; single lab","pmids":["19357131"],"is_preprint":false},{"year":2012,"finding":"Excitotoxicity causes neuronal death via imbalance of TrkB isoforms: calpain cleaves full-length TrkB (TrkB-FL) producing a truncated form similar to inactive TrkB-T1, while mRNA of TrkB-T1 is upregulated. Restoring TrkB-FL/TrkB-T1 balance via lentiviral TrkB-T1 interference and TrkB-FL overexpression protects neurons from excitotoxic death.","method":"Calpain cleavage assay, Western blot, RT-PCR, lentiviral gene delivery (TrkB-T1 knockdown + TrkB-FL overexpression), excitotoxicity neuronal survival assay, stroke patient tissue analysis","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mechanistic cleavage identified biochemically plus functional rescue with lentiviral intervention; single lab","pmids":["22258407"],"is_preprint":false},{"year":2012,"finding":"TrkB-Shc truncated isoform reduces phosphorylated full-length TrkB (TrkB-TK+) protein levels in response to BDNF, suggesting TrkB-Shc promotes degradation of activated TrkB-TK+ complexes to prevent TrkB overactivation; conversely, TrkB-Shc protein stability is increased following BDNF exposure.","method":"Transient overexpression in CHOK1 cells, BDNF stimulation, immunoblot for phospho-TrkB and TrkB isoform protein levels","journal":"Biochemical and biophysical research communications","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, overexpression in non-neuronal cells, single method (Western blot)","pmids":["22425982"],"is_preprint":false},{"year":2013,"finding":"Oligodendrocyte-specific TrkB deletion disrupts myelination: conditional TrkB knockout in oligodendrocytes reduces myelin protein expression and myelin thickness in CNS white matter tracts during development without affecting the number of mature oligodendrocytes or myelinated axons, demonstrating a direct role for TrkB in myelin ensheathment. TrkB deletion in oligodendroglia also increases OPC proliferation, an effect dependent on TrkC and p75 expression.","method":"Conditional knockout mice (oligodendrocyte-specific TrkB deletion), myelin protein expression assay, electron microscopy for myelin thickness, OPC density quantification, in vitro TrkB knockdown in OPCs","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — cell-type specific conditional knockout with multiple orthogonal readouts (protein expression, EM, cell counting, in vitro validation)","pmids":["23486965"],"is_preprint":false},{"year":2013,"finding":"Retinoic acid receptor α (RARα) binds to and transactivates the TrkB promoter via a putative retinoic acid response element, providing a transcriptional mechanism by which retinoid signaling upregulates TrkB expression.","method":"In vitro transcription/promoter binding assay, chromatin immunoprecipitation/reporter assay for RARα binding to TrkB promoter","journal":"Cerebral cortex","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, single method (promoter transactivation), not independently replicated","pmids":["23960204"],"is_preprint":false},{"year":2014,"finding":"Oocyte-specific deletion of Ntrk2 causes post-pubertal oocyte death and infertility. Oocytes lacking NTRK2 fail to activate PI3K-AKT signaling in response to gonadotropins. The preovulatory gonadotropin surge rapidly induces full-length NTRK2 (NTRK2.FL) expression in oocytes, and BDNF + kisspeptin act cooperatively (via oocyte NTRK2.T1 and KISS1R) to mediate gonadotropin-induced NTRK2.FL upregulation, establishing NTRK2-AKT as the survival pathway activated at the onset of reproductive cyclicity.","method":"Oocyte-specific conditional knockout (Ntrk2), gonadotropin stimulation assays, PI3K-AKT activation assays, cell line co-expression of NTRK2.T1 + KISS1R with BDNF/kisspeptin stimulation","journal":"Endocrinology","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional knockout with multiple cellular and molecular readouts; cooperative ligand signaling established in cell line","pmids":["24877631"],"is_preprint":false},{"year":2015,"finding":"Slitrk5 directly interacts with TrkB receptors and mediates BDNF-dependent TrkB trafficking: under basal conditions Slitrk5 preferentially binds PTPδ, but upon BDNF stimulation, Slitrk5 shifts to cis-interactions with TrkB. Absence of Slitrk5 reduces ligand-dependent TrkB recycling and alters BDNF responsiveness. Slitrk5 recruits the Rab11 effector Rab11-FIP3 to direct TrkB to Rab11-positive recycling endosomes.","method":"Co-immunoprecipitation, structured illumination microscopy, receptor recycling assays, Rab11-FIP3 pulldown, Slitrk5 knockout mouse analysis","journal":"Developmental cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP, super-resolution microscopy, receptor recycling assays, and genetic knockout in one study; multiple orthogonal methods","pmids":["26004511"],"is_preprint":false},{"year":2015,"finding":"BDNF acting via truncated TrkB-T1 (not full-length TrkB-FL) promotes internalization of glycine transporters GlyT1 and GlyT2 in astrocytes through Rho-GTPase signaling: BDNF decreases Vmax but not Km of glycine transport (consistent with transporter internalization); dynasore (dynamin/clathrin inhibitor) prevents this effect; Rho-family blocker (toxin B) and TrkB-T knockdown abolish it, while PLCγ, PI3K, and MAPK inhibitors do not.","method":"Radiolabeled glycine transport assay ([3H]glycine), pharmacological inhibitors, RNAi (TrkB-T knockdown), immunofluorescence for transporter endosomal localization","journal":"Glia","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple pharmacological and RNAi approaches in primary astrocytes; single lab","pmids":["26200505"],"is_preprint":false},{"year":2019,"finding":"Local TrkB activation at neurite ends initiates actin waves and specifies axonal fate: optogenetic activation (Opto-cytTrkB) of TrkB signaling in the distal neurite triggers F-actin wave generation from the somato-neuritic area toward the neurite end; TrkB signaling connects distally activated Rac1 to proximal signaling pathways; local TrkB activation relocates the axon initial segment organizer ankyrinG and confers axonal identity to the stimulated neurite.","method":"Optogenetics (Opto-cytTrkB), live imaging of actin waves, immunostaining for ankyrinG, Rac1 activity assays","journal":"Cell chemical biology","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — optogenetic spatial activation with live imaging and molecular markers; novel approach but single lab","pmids":["31678045"],"is_preprint":false},{"year":2020,"finding":"A truncated NTRK2 splice variant TrkB.T1 (kinase-deficient) enhances PDGF-driven gliomas in vivo and augments PDGF-induced Akt and STAT3 signaling in vitro in a ligand-independent fashion; next-generation sequencing broadly implicates TrkB.T1 in PI3K signaling cascades.","method":"In vivo glioma model (PDGF-driven), in vitro Akt/STAT3 signaling assays, next-generation sequencing, splice variant characterization","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo tumor model combined with in vitro signaling assays; single lab with multiple readouts","pmids":["32532995"],"is_preprint":false},{"year":2020,"finding":"TrkB-expressing paraventricular hypothalamic (PVH) neurons suppress appetite through multiple neurocircuits: selective Ntrk2 deletion in PVH causes severe hyperphagic obesity; PVHTrkB neurons project to both VMH and LPBN; Ntrk2 deletion in either projection causes hyperphagia and obesity; BDNF increases firing of PVHTrkB neurons, demonstrating TrkB as a key regulator of PVH appetite circuits.","method":"Conditional Ntrk2 knockout (PVH-specific), chemogenetic activation/inhibition (DREADD), axonal projection tracing, electrophysiology, BDNF stimulation","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional knockout, chemogenetics, circuit tracing, and electrophysiology combined in one study","pmids":["32265438"],"is_preprint":false},{"year":2021,"finding":"Both typical and fast-acting antidepressants directly bind to the transmembrane domain (TMD) of TrkB dimers, facilitating synaptic TrkB localization and its activation by BDNF. The TMD of TrkB has a cholesterol-sensing function mediating synaptic effects of cholesterol. Mutation of the TrkB antidepressant-binding motif impairs cellular, behavioral, and plasticity-promoting responses to antidepressants in vitro and in vivo. Atomistic molecular dynamics simulations defined the binding site at the TMD of TrkB dimers.","method":"Molecular dynamics simulations, radioligand binding assays, site-directed mutagenesis of antidepressant-binding motif, synaptic localization assays, in vitro and in vivo behavioral/plasticity assays","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — computational structure prediction validated by mutagenesis, binding assays, and in vivo functional experiments; multiple orthogonal methods","pmids":["33606976"],"is_preprint":false},{"year":2021,"finding":"Postsynaptic TrkB in CA1 neurons is required for ketamine-induced synaptic potentiation and rapid antidepressant action: deletion of TrkB only in CA1 (postsynaptic) but not CA3 (presynaptic) eliminates ketamine-induced synaptic potentiation; ketamine elicits dynamin1-dependent TrkB activation and downstream signaling.","method":"Region-specific BDNF/TrkB deletion (CA3 vs CA1), electrophysiology (synaptic potentiation), dynamin1 dependence assay, behavioral antidepressant assay","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — cell-type specific conditional deletion with electrophysiology and behavioral readouts; dynamin1-dependence mechanistically links TrkB trafficking to ketamine's action","pmids":["34407417"],"is_preprint":false},{"year":2022,"finding":"BDNF and TrkB form an autocrine loop in senescent cells: senescent cells express high TrkB (NTRK2) and secrete BDNF (SASP factor); TrkB activation by BDNF promotes senescent cell survival by activating ERK5 and elevating BCL2L2; TrkB inhibition selectively triggers apoptosis of senescent cells and reduces senescent cell accumulation in aged mouse organs.","method":"Drug library screen, TrkB inhibitor treatment, BDNF ablation, ERK5/BCL2L2 signaling assays, apoptosis assays, in vivo aged mouse organ analysis","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — drug screen plus mechanistic dissection (ERK5, BCL2L2) plus in vivo validation in aged mice; multiple orthogonal methods","pmids":["36266274"],"is_preprint":false},{"year":2022,"finding":"Oxytocin rapidly transactivates TrkB receptors in primary cortical neurons and in acute brain slices, increasing TrkB tyrosine phosphorylation via the oxytocin GPCR (not the vasopressin receptor). TrkB transactivation by oxytocin enhances gephyrin clustering, suggesting a mechanism for oxytocin modulation of inhibitory synapses.","method":"Immunoblot for phospho-TrkB, acute brain slice preparation (bath application), primary cortical culture, receptor pharmacology, gephyrin clustering immunostaining","journal":"Frontiers in molecular neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — biochemical phosphorylation assays in primary neurons and acute slices with pharmacological dissection; single lab","pmids":["35721318"],"is_preprint":false},{"year":2022,"finding":"TrkB activation via BDNF/TrkB signaling activates Akt which phosphorylates and inhibits asparagine endopeptidase (AEP); TrkB agonist R13 increases osteoprotegerin (OPG) through TrkB→CREB activation, blocking trabecular bone loss; TrkB also inhibits the C/EBPβ/AEP pathway to suppress RANKL-induced osteoclastogenesis.","method":"TrkB agonist (R13/7,8-DHF) treatment, ovariectomy (OVX) mouse model, AEP knockout mice, AEP phosphorylation assays, OPG/RANKL measurement, osteoclastogenesis assay (RAW264.7), CREB activation assay","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological and genetic (AEP KO, OVX) approaches with multiple molecular readouts; single lab","pmids":["35973996"],"is_preprint":false},{"year":2023,"finding":"LSD and psilocin directly bind to TrkB with affinities ~1,000-fold higher than other antidepressants, binding at distinct but partially overlapping sites within the TMD of TrkB dimers relative to antidepressant binding sites. Psychedelic effects on neurotrophic signaling, plasticity, and antidepressant-like behavior depend on TrkB binding and promotion of endogenous BDNF signaling but are independent of 5-HT2A receptor activation; LSD-induced head twitching is dependent on 5-HT2A and independent of TrkB.","method":"Radioligand binding assays, molecular dynamics simulations, TrkB-binding site mutagenesis, neurotrophic signaling assays, plasticity assays, in vivo behavioral assays in mice (antidepressant-like behavior, head twitch response)","journal":"Nature neuroscience","confidence":"High","confidence_rationale":"Tier 1 / Strong — binding assays, mutagenesis, and multiple in vivo behavioral experiments; mechanistically dissects TrkB from 5-HT2A contributions","pmids":["37280397"],"is_preprint":false},{"year":2024,"finding":"Cortical BDNF-TrkB-CREB signaling in layer 5 pyramidal neurons regulates sleep slow-wave activity (SWA): pharmacological and optogenetic perturbations show TrkB activation is required for SWA buildup; TrkB activation enriches ubiquitin and proteasome subunits (by proteomic analysis); BDNF effects on synaptic strength increase SWA independently of neuronal firing per se.","method":"Pharmacology (TrkB inhibitor), optogenetic perturbations, EEG (SWA measurement), RNA sequencing/transcriptomics, proteomics, mathematical modeling, layer 5 cell-specific analysis","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological and optogenetic interventions with electrophysiology and proteomics; localization to L5 neurons; single lab","pmids":["39046880"],"is_preprint":false},{"year":2018,"finding":"BDNF-TrkB signaling in oxytocin (OXT) neurons is required for maternal behavior: ablation of TrkB selectively in OXT neurons partially recapitulates maternal care impairments seen in BDNF-deficient females; BDNF signaling through TrkB in OXT neurons regulates oxytocin expression during development.","method":"OXT neuron-specific TrkB conditional knockout, maternal behavior assessment, oxytocin expression analysis, translating ribosome affinity purification (TRAP) RNA-seq","journal":"eLife","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cell-type specific conditional knockout with behavioral and molecular readouts; single lab","pmids":["30192229"],"is_preprint":false},{"year":2021,"finding":"Adult TrkB signaling in parvalbumin (PV) interneurons of the medial prefrontal cortex is essential for maintenance of PV interneuron integrity, local network dynamics, and γ oscillations: viral dominant-negative trkB expression in mPFC PV interneurons reduces PV inhibition, increases broadband LFP activity, and increases aggression, demonstrating that adult BDNF/trkB signaling sustains PV interneuron function.","method":"Viral vector (dominant-negative trkB), immunohistochemistry, local field potential (LFP) recording, behavioral assays","journal":"The Journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — viral dominant-negative approach in specific cell type with electrophysiology and behavior; single lab","pmids":["33593856"],"is_preprint":false},{"year":2018,"finding":"Overexpression of truncated (inactive) TrkB in the orbitofrontal cortex or dorsomedial striatum interferes with TrkB phosphorylation and ERK42/44 phosphorylation, abolishing goal-directed action selection. In the dorsolateral striatum, truncated TrkB overexpression blocks habit formation, demonstrating that corticostriatal TrkB-ERK signaling is necessary for balancing goal-directed versus habitual behaviors.","method":"Viral-mediated truncated TrkB overexpression in specific brain regions, immunoblot for phospho-TrkB and phospho-ERK, operant conditioning behavioral assays","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — region-specific viral intervention with signaling assays and behavioral readouts; single lab","pmids":["29540698"],"is_preprint":false},{"year":2015,"finding":"TrkB kinase activity at neuromuscular junctions (NMJ) is required for presynaptic terminal maintenance: inhibition of TrkB kinase activity in TrkBF616A mice reduces presynaptic terminal volume (~20%) and motor end-plate area (~10%); in early old age, TrkB kinase inhibition significantly reduces NMJ pre/postsynaptic overlap and increases denervated NMJs (~20%).","method":"Chemical-genetic TrkB kinase inhibition (TrkBF616A + 1NMPP1), confocal microscopy of NMJ morphology, quantification of denervation","journal":"Experimental gerontology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — chemical-genetic approach with defined structural readouts at NMJ; single lab","pmids":["26517952"],"is_preprint":false},{"year":2014,"finding":"TrkB kinase activity inhibition suppresses kindled seizures: inducible conditional TrkB knockout reduces behavioral seizure severity; chemical-genetic TrkB kinase inhibition (TrkBF616A + 1NMPP1) reversibly elevates focal electrographic and generalized seizure thresholds in kindled mice, establishing TrkB kinase as an antiseizure target.","method":"Inducible conditional TrkB knockout (Act-CreER TrkBflox/flox), chemical-genetic approach (TrkBF616A + 1NMPP1), kindling model, electrographic seizure threshold measurement","journal":"Epilepsia","confidence":"High","confidence_rationale":"Tier 2 / Strong — two independent genetic approaches (conditional KO and chemical-genetic) with electrophysiology in same model","pmids":["24903749"],"is_preprint":false},{"year":2012,"finding":"RNA aptamer C4-3 binds the extracellular domain of TrkB with high affinity (Kd ~2 nM), acts as a partial TrkB agonist, exhibits neuroprotective effects in cortical neurons, and activates TrkB upon hippocampal infusion in mice, demonstrating the extracellular domain as a functional binding/activation site.","method":"Recombinant protein binding assays (Kd measurement), cell-based signaling assays, cortical neuron neuroprotection assay, in vivo TrkB activation (hippocampal infusion)","journal":"Molecular pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple binding and functional assays in vitro and in vivo; single lab","pmids":["22752556"],"is_preprint":false}],"current_model":"NTRK2 (TrkB) is a transmembrane receptor tyrosine kinase that is activated by BDNF, NT-4, and NT-3; upon ligand binding, TrkB undergoes autophosphorylation and recruits PLCγ (required for hippocampal LTP via CaMKIV/CREB), Shc/MAPK, and PI3K/Akt signaling cascades; antidepressants and psychedelics directly bind its transmembrane domain to allosterically potentiate BDNF signaling; TrkB also mediates cholesterol-dependent synaptic localization, is transactivated by oxytocin GPCRs, and its kinase-deficient truncated isoform TrkB.T1 modulates full-length TrkB activity through dominant-negative effects, regulates glycine transporter internalization via Rho-GTPase, and promotes senescent cell survival via ERK5/BCL2L2; circuit-level, TrkB in paraventricular hypothalamic neurons suppresses appetite, in CA1 postsynaptic neurons mediates ketamine's rapid antidepressant effects, and in parvalbumin interneurons maintains prefrontal network dynamics."},"narrative":{"mechanistic_narrative":"NTRK2 (TrkB) is a brain-enriched transmembrane glycoprotein receptor tyrosine kinase that transduces neurotrophin signals to control neuronal survival, synaptic plasticity, and circuit-level behavior [PMID:2555172, PMID:8264643]. It is activated by BDNF and by NT-4/NT-4, which engage partially distinct extracellular contact residues, triggering receptor autophosphorylation and recruitment of downstream effectors [PMID:1375038]. Ligand binding bifurcates into parallel cascades whose physiological outputs are separable: phosphorylation of a PLCγ docking site drives CaMKIV/CREB activation required for hippocampal LTP, whereas a distinct Shc docking site couples to MAPK, and a PI3K/Akt arm supports survival and anti-apoptotic signaling [PMID:12367511, PMID:15329723]. Through these outputs TrkB is essential for presynaptic maturation and synaptogenesis of hippocampal connections [PMID:9736654], oligodendrocyte myelin ensheathment [PMID:23486965], and the integrity of prefrontal parvalbumin interneuron network dynamics [PMID:33593856]; at the circuit level it acts in paraventricular hypothalamic neurons to suppress appetite [PMID:32265438] and in postsynaptic CA1 neurons to mediate ketamine's rapid antidepressant effect via dynamin1-dependent activation [PMID:34407417]. TrkB receptor availability is shaped by its truncated, kinase-deficient isoforms (TrkB.T1/TrkB-Shc), which act as dominant-negative modulators of full-length receptor responsiveness and can signal independently to drive glycine transporter internalization and tumor-promoting PI3K/Akt-STAT3 output [PMID:8978665, PMID:31678045, PMID:32532995], and by Slitrk5-directed recycling through Rab11 endosomes [PMID:26004511]. Beyond canonical neurotrophins, TrkB is transactivated by oxytocin GPCR signaling [PMID:35721318] and is directly bound at its transmembrane domain by antidepressants and psychedelics, which allosterically potentiate BDNF signaling in a cholesterol-sensitive manner [PMID:33606976, PMID:37280397]. TrkB function also extends to ovarian follicle and oocyte survival via PI3K-AKT [PMID:24877631], senescent-cell survival via an autocrine BDNF loop activating ERK5/BCL2L2 [PMID:36266274], and bone homeostasis [PMID:35973996], and TrkB kinase activity is an antiseizure target [PMID:24903749].","teleology":[{"year":1989,"claim":"Established the molecular identity of TrkB as a nervous-system-enriched receptor tyrosine kinase, defining the protein class whose ligands and signaling would later be dissected.","evidence":"cDNA cloning and glycoprotein reconstitution with in situ hybridization","pmids":["2555172"],"confidence":"High","gaps":["Did not identify the activating ligand","No downstream signaling defined"]},{"year":1992,"claim":"Identified NT-4 as a TrkB ligand and showed via Cys345Ser mutagenesis that NT-4 and BDNF use partially distinct contact residues, revealing ligand-selective receptor engagement.","evidence":"Radioligand displacement, tyrosine phosphorylation, transformation/differentiation assays, site-directed mutagenesis","pmids":["1375038"],"confidence":"High","gaps":["Did not map the full ligand-binding interface","NT-3 contribution not addressed here"]},{"year":1994,"claim":"Connected TrkB activation to a defined set of downstream effectors (PLCγ1, ERK1/2, PI3K) and survival/differentiation outputs, framing TrkB as a multi-pathway survival receptor.","evidence":"Phospho-immunoblots and downstream activation/survival assays in BDNF-expressing neuroblastoma cells","pmids":["8264643"],"confidence":"Medium","gaps":["Single cell line, single lab","Did not establish which pathway controls which phenotype"]},{"year":1996,"claim":"Showed truncated TrkB isoforms act as dominant-negative receptors, establishing that the catalytic/non-catalytic isoform ratio tunes BDNF responsiveness.","evidence":"Isoform co-expression and survival assays in primary sympathetic neurons","pmids":["8978665"],"confidence":"Medium","gaps":["Mechanism of dominant-negative action not resolved","Single lab"]},{"year":1998,"claim":"Demonstrated in vivo that TrkB is required for presynaptic maturation and synaptogenesis, moving TrkB from in vitro signaling to organ-level neural circuit development.","evidence":"Knockout mouse analysis with tract tracing, EM, and immunocytochemistry","pmids":["9736654"],"confidence":"High","gaps":["Cell-autonomous vs network effects not separated","Did not link a specific signaling arm to the phenotype"]},{"year":2002,"claim":"Genetically separated the PLCγ and Shc docking pathways, assigning hippocampal LTP/CaMKIV/CREB to PLCγ and MAPK activation to Shc, establishing parallel TrkB signaling routes with distinct functions.","evidence":"Docking-site knockin mice with LTP electrophysiology and BDNF-stimulated signaling assays","pmids":["12367511"],"confidence":"High","gaps":["PI3K arm not addressed in this design","Behavioral consequences not fully mapped"]},{"year":2004,"claim":"Showed TrkB/PI3K-Akt suppresses anoikis and drives metastasis, extending TrkB survival signaling to non-neural epithelial and oncogenic contexts.","evidence":"Genome-wide anoikis-suppression screen with pathway inhibition and mouse metastasis model","pmids":["15329723"],"confidence":"High","gaps":["Ligand dependence in tumors not fully defined","Did not address isoform contributions"]},{"year":2009,"claim":"Established a peripheral reproductive role for TrkB in ovarian follicle assembly via induction of FSH receptor, broadening TrkB function beyond the nervous system.","evidence":"Ntrk2 knockout mouse follicle counts, FSHR expression, NT-4 treatment","pmids":["19357131"],"confidence":"Medium","gaps":["Downstream signaling to FSHR not defined","Single lab"]},{"year":2012,"claim":"Defined excitotoxic regulation of TrkB by calpain cleavage and TrkB-T1 upregulation, and a ligand-trafficking control by TrkB-Shc, mechanistically linking isoform balance to neuronal death.","evidence":"Calpain cleavage and lentiviral rescue in neurons (22258407); overexpression immunoblots in CHOK1 cells (22425982)","pmids":["22258407","22425982"],"confidence":"Medium","gaps":["TrkB-Shc work limited to overexpression in non-neuronal cells, single method","Endogenous relevance of the degradation mechanism unconfirmed"]},{"year":2013,"claim":"Extended TrkB function to oligodendrocyte myelination and identified RARα as a transcriptional activator of the TrkB promoter, addressing how TrkB output and expression are regulated.","evidence":"Oligodendrocyte-specific conditional knockout with EM/myelin readouts (23486965); promoter transactivation/ChIP assay (23960204)","pmids":["23486965","23960204"],"confidence":"High","gaps":["RARα finding is single-lab, single-method, not replicated","Signaling arm mediating myelination not pinpointed"]},{"year":2014,"claim":"Showed gonadotropin-induced oocyte NTRK2.FL-AKT signaling is required for oocyte survival, with cooperative BDNF/kisspeptin input via NTRK2.T1 and KISS1R, defining a reproductive survival pathway.","evidence":"Oocyte-specific Ntrk2 knockout, gonadotropin stimulation, PI3K-AKT assays, cell-line co-expression","pmids":["24877631"],"confidence":"High","gaps":["Mechanism of NTRK2.T1/KISS1R cooperativity not structurally defined","Single lab"]},{"year":2015,"claim":"Resolved post-translational control of TrkB trafficking: Slitrk5 directs ligand-dependent recycling via Rab11, while truncated TrkB-T1 drives glycine transporter internalization through Rho-GTPase, expanding the non-kinase roles of TrkB.","evidence":"Reciprocal Co-IP, super-resolution imaging, recycling assays, Slitrk5 KO (26004511); glycine transport, pharmacology and RNAi in astrocytes (26200505)","pmids":["26004511","26200505"],"confidence":"Medium","gaps":["Glycine transporter work is single lab","How TrkB-T1 engages Rho-GTPase mechanistically not resolved"]},{"year":2015,"claim":"Demonstrated TrkB kinase activity sustains neuromuscular junction presynaptic terminals, particularly with aging, linking kinase function to peripheral synapse maintenance.","evidence":"Chemical-genetic kinase inhibition (TrkBF616A + 1NMPP1) with NMJ morphometry","pmids":["26517952"],"confidence":"Medium","gaps":["Downstream effectors at NMJ not identified","Single lab"]},{"year":2018,"claim":"Identified TrkB signaling within oxytocin neurons as a developmental driver of oxytocin expression and maternal behavior, embedding TrkB in social/behavioral circuits.","evidence":"OXT-neuron-specific TrkB conditional knockout with behavioral and TRAP RNA-seq readouts","pmids":["30192229"],"confidence":"Medium","gaps":["Signaling arm mediating oxytocin regulation not defined","Single lab"]},{"year":2018,"claim":"Showed corticostriatal TrkB-ERK signaling is required to balance goal-directed versus habitual behaviors, mapping TrkB kinase output onto defined action-selection circuits.","evidence":"Region-specific truncated TrkB overexpression with phospho-ERK assays and operant behavior","pmids":["29540698"],"confidence":"Medium","gaps":["Dominant-negative overexpression may have off-target effects","Single lab"]},{"year":2019,"claim":"Used spatial optogenetic activation to show local TrkB signaling initiates actin waves and specifies axonal identity, revealing a cell-biological role in neuronal polarization.","evidence":"Opto-cytTrkB activation with live actin imaging, Rac1 assays, ankyrinG staining","pmids":["31678045"],"confidence":"Medium","gaps":["Endogenous spatial ligand cues not addressed","Single lab"]},{"year":2020,"claim":"Established TrkB as a key node in PVH appetite circuits and showed truncated TrkB.T1 can drive ligand-independent glioma growth, linking TrkB to opposite physiological and pathological survival contexts.","evidence":"PVH-specific conditional knockout with chemogenetics/circuit tracing (32265438); PDGF glioma model with Akt/STAT3 assays (32532995)","pmids":["32265438","32532995"],"confidence":"High","gaps":["Mechanism of TrkB.T1 ligand-independent signaling not fully defined","Glioma study single lab/Medium confidence"]},{"year":2021,"claim":"Discovered antidepressants directly bind the TrkB transmembrane domain to potentiate BDNF signaling in a cholesterol-sensitive manner, and that postsynaptic CA1 TrkB mediates ketamine's rapid action, redefining TrkB as a direct drug target.","evidence":"MD simulations, binding assays, TMD-motif mutagenesis, in vivo behavior (33606976); CA1/CA3-specific deletion with electrophysiology and dynamin1 dependence (34407417)","pmids":["33606976","34407417"],"confidence":"High","gaps":["Structural validation of the TMD binding pocket beyond simulation incomplete","Generality across antidepressant classes not exhaustively mapped"]},{"year":2021,"claim":"Showed adult TrkB signaling maintains prefrontal parvalbumin interneuron integrity and γ oscillations, assigning TrkB a continuous role in mature inhibitory network function.","evidence":"Viral dominant-negative trkB in mPFC PV interneurons with LFP recording and behavior","pmids":["33593856"],"confidence":"Medium","gaps":["Dominant-negative may affect related receptors","Single lab"]},{"year":2022,"claim":"Extended TrkB's reach to senescent-cell survival (autocrine BDNF→ERK5/BCL2L2), oxytocin GPCR transactivation of TrkB at inhibitory synapses, and bone homeostasis, demonstrating broad TrkB signaling versatility.","evidence":"Drug screen + ERK5/BCL2L2 assays in aged mice (36266274); phospho-TrkB assays with oxytocin pharmacology (35721318); TrkB agonist/AEP KO/OVX bone models (35973996)","pmids":["36266274","35721318","35973996"],"confidence":"Medium","gaps":["Oxytocin and bone findings each single lab","Cross-talk mechanism of GPCR transactivation not structurally defined"]},{"year":2023,"claim":"Showed psychedelics (LSD, psilocin) bind TrkB with ~1000-fold higher affinity than antidepressants at a partially overlapping TMD site, and that their plasticity/antidepressant effects are TrkB-dependent but 5-HT2A-independent, dissociating two drug-receptor axes.","evidence":"Radioligand binding, MD simulations, TMD mutagenesis, and in vivo behavioral assays separating TrkB from 5-HT2A","pmids":["37280397"],"confidence":"High","gaps":["Co-crystal structure of psychedelic-bound TrkB not reported","Relationship to clinical efficacy untested"]},{"year":2024,"claim":"Linked cortical BDNF-TrkB-CREB signaling in layer 5 neurons to sleep slow-wave activity, placing TrkB synaptic-strength control upstream of a defined sleep electrophysiological output.","evidence":"Pharmacology/optogenetics with EEG, transcriptomics and proteomics in layer 5 neurons","pmids":["39046880"],"confidence":"Medium","gaps":["Mechanistic role of the enriched ubiquitin/proteasome subunits not established","Single lab"]},{"year":null,"claim":"How distinct extracellular vs transmembrane binding modes (neurotrophins, RNA aptamer C4-3, antidepressants, psychedelics, GPCR transactivation) are integrated into graded, context-specific TrkB output across diverse cell types remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified structural model coupling TMD allostery to kinase activation","Cell-type determinants of isoform ratio and signaling-arm selection not defined","How non-neuronal TrkB roles (bone, senescence, ovary, tumor) are gated remains open"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,1,2,5,29]},{"term_id":"GO:0140657","term_label":"ATP-dependent activity","supporting_discovery_ids":[0]},{"term_id":"GO:0048018","term_label":"receptor ligand activity","supporting_discovery_ids":[1,2]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[1,30]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[3,9]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,18,13]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[13]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[2,5,6]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[4,5,17,19]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[4,10,15]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[6,8,20]},{"term_id":"R-HSA-1474165","term_label":"Reproduction","supporting_discovery_ids":[7,12]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[6,16,20]}],"complexes":[],"partners":["BDNF","NTF4","SLITRK5","KISS1R"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q16620","full_name":"BDNF/NT-3 growth factors receptor","aliases":["GP145-TrkB","Trk-B","Neurotrophic tyrosine kinase receptor type 2","TrkB tyrosine kinase","Tropomyosin-related kinase B"],"length_aa":822,"mass_kda":92.0,"function":"Receptor tyrosine kinase involved in the development and the maturation of the central and the peripheral nervous systems through regulation of neuron survival, proliferation, migration, differentiation, and synapse formation and plasticity (By similarity). Receptor for BDNF/brain-derived neurotrophic factor and NTF4/neurotrophin-4. Alternatively can also bind NTF3/neurotrophin-3 which is less efficient in activating the receptor but regulates neuron survival through NTRK2 (PubMed:15494731, PubMed:7574684). Upon ligand-binding, undergoes homodimerization, autophosphorylation and activation (PubMed:15494731). Recruits, phosphorylates and/or activates several downstream effectors including SHC1, FRS2, SH2B1, SH2B2 and PLCG1 that regulate distinct overlapping signaling cascades. Through SHC1, FRS2, SH2B1, SH2B2 activates the GRB2-Ras-MAPK cascade that regulates for instance neuronal differentiation including neurite outgrowth. Through the same effectors controls the Ras-PI3 kinase-AKT1 signaling cascade that mainly regulates growth and survival. Through PLCG1 and the downstream protein kinase C-regulated pathways controls synaptic plasticity. Thereby, plays a role in learning and memory by regulating both short term synaptic function and long-term potentiation. PLCG1 also leads to NF-Kappa-B activation and the transcription of genes involved in cell survival. Hence, it is able to suppress anoikis, the apoptosis resulting from loss of cell-matrix interactions. May also play a role in neutrophin-dependent calcium signaling in glial cells and mediate communication between neurons and glia","subcellular_location":"Cell membrane; Endosome membrane; Early endosome membrane; Cell projection, axon; Cell projection, dendrite; Cytoplasm, perinuclear region; Postsynaptic density","url":"https://www.uniprot.org/uniprotkb/Q16620/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/NTRK2","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/NTRK2","total_profiled":1310},"omim":[{"mim_id":"617830","title":"DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 58; DEE58","url":"https://www.omim.org/entry/617830"},{"mim_id":"617361","title":"TRANSMEMBRANE PROTEIN 108; TMEM108","url":"https://www.omim.org/entry/617361"},{"mim_id":"615759","title":"KINASE D-INTERACTING SUBSTRATE, 220-KD; KIDINS220","url":"https://www.omim.org/entry/615759"},{"mim_id":"613886","title":"OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD","url":"https://www.omim.org/entry/613886"},{"mim_id":"608894","title":"ABELSON HELPER INTEGRATION SITE 1; AHI1","url":"https://www.omim.org/entry/608894"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Plasma membrane","reliability":"Supported"},{"location":"Vesicles","reliability":"Additional"},{"location":"Primary cilium tip","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":233.3},{"tissue":"thyroid gland","ntpm":118.0}],"url":"https://www.proteinatlas.org/search/NTRK2"},"hgnc":{"alias_symbol":["TRKB"],"prev_symbol":[]},"alphafold":{"accession":"Q16620","domains":[{"cath_id":"3.80.10.10","chopping":"36-149","consensus_level":"high","plddt":88.9423,"start":36,"end":149},{"cath_id":"2.60.40.10","chopping":"194-282","consensus_level":"medium","plddt":89.1925,"start":194,"end":282},{"cath_id":"2.60.40.10","chopping":"293-375","consensus_level":"medium","plddt":91.7541,"start":293,"end":375},{"cath_id":"3.30.200.20","chopping":"527-619","consensus_level":"medium","plddt":84.1942,"start":527,"end":619},{"cath_id":"1.10.510.10","chopping":"624-815","consensus_level":"medium","plddt":87.6902,"start":624,"end":815}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q16620","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q16620-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q16620-F1-predicted_aligned_error_v6.png","plddt_mean":77.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=NTRK2","jax_strain_url":"https://www.jax.org/strain/search?query=NTRK2"},"sequence":{"accession":"Q16620","fasta_url":"https://rest.uniprot.org/uniprotkb/Q16620.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q16620/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q16620"}},"corpus_meta":[{"pmid":"19927149","id":"PMC_19927149","title":"TrkB signalling pathways in LTP and learning.","date":"2009","source":"Nature reviews. Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/19927149","citation_count":841,"is_preprint":false},{"pmid":"23817572","id":"PMC_23817572","title":"Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma.","date":"2013","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23817572","citation_count":649,"is_preprint":false},{"pmid":"20186705","id":"PMC_20186705","title":"Postsynaptic BDNF-TrkB signaling in synapse maturation, plasticity, and disease.","date":"2010","source":"Developmental neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/20186705","citation_count":571,"is_preprint":false},{"pmid":"2555172","id":"PMC_2555172","title":"trkB, a novel tyrosine protein kinase receptor expressed during mouse neural development.","date":"1989","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/2555172","citation_count":560,"is_preprint":false},{"pmid":"33606976","id":"PMC_33606976","title":"Antidepressant drugs act by directly binding to TRKB neurotrophin receptors.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33606976","citation_count":512,"is_preprint":false},{"pmid":"15329723","id":"PMC_15329723","title":"Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB.","date":"2004","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/15329723","citation_count":487,"is_preprint":false},{"pmid":"12367511","id":"PMC_12367511","title":"Mechanism of TrkB-mediated hippocampal long-term potentiation.","date":"2002","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/12367511","citation_count":374,"is_preprint":false},{"pmid":"8264643","id":"PMC_8264643","title":"Expression and function of TRK-B and BDNF in human neuroblastomas.","date":"1994","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8264643","citation_count":343,"is_preprint":false},{"pmid":"37280397","id":"PMC_37280397","title":"Psychedelics promote plasticity by directly binding to BDNF receptor TrkB.","date":"2023","source":"Nature neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/37280397","citation_count":340,"is_preprint":false},{"pmid":"1375038","id":"PMC_1375038","title":"The trkB tyrosine protein kinase is a receptor for neurotrophin-4.","date":"1992","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/1375038","citation_count":294,"is_preprint":false},{"pmid":"9736654","id":"PMC_9736654","title":"TrkB and TrkC signaling are required for maturation and synaptogenesis of hippocampal connections.","date":"1998","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/9736654","citation_count":207,"is_preprint":false},{"pmid":"23670594","id":"PMC_23670594","title":"TrkB receptor signalling: implications in neurodegenerative, psychiatric and proliferative disorders.","date":"2013","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/23670594","citation_count":200,"is_preprint":false},{"pmid":"22341689","id":"PMC_22341689","title":"Truncated TrkB: beyond a dominant negative receptor.","date":"2012","source":"Cytokine & growth factor reviews","url":"https://pubmed.ncbi.nlm.nih.gov/22341689","citation_count":165,"is_preprint":false},{"pmid":"27657046","id":"PMC_27657046","title":"Neuroprotection, Growth Factors and BDNF-TrkB Signalling in Retinal Degeneration.","date":"2016","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/27657046","citation_count":160,"is_preprint":false},{"pmid":"21215389","id":"PMC_21215389","title":"The CREB1-BDNF-NTRK2 pathway in depression: multiple gene-cognition-environment interactions.","date":"2011","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/21215389","citation_count":131,"is_preprint":false},{"pmid":"23486965","id":"PMC_23486965","title":"Oligodendroglial expression of TrkB independently regulates myelination and progenitor cell proliferation.","date":"2013","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/23486965","citation_count":124,"is_preprint":false},{"pmid":"9049830","id":"PMC_9049830","title":"Expression of TrkA, TrkB and TrkC in human neuroblastomas.","date":"1997","source":"Journal of neuro-oncology","url":"https://pubmed.ncbi.nlm.nih.gov/9049830","citation_count":120,"is_preprint":false},{"pmid":"20662941","id":"PMC_20662941","title":"Increased BDNF levels and NTRK2 gene association suggest a disruption of BDNF/TrkB signaling in autism.","date":"2010","source":"Genes, brain, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/20662941","citation_count":107,"is_preprint":false},{"pmid":"15921851","id":"PMC_15921851","title":"Biological effects of TrkA and TrkB receptor signaling in neuroblastoma.","date":"2005","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/15921851","citation_count":100,"is_preprint":false},{"pmid":"8978665","id":"PMC_8978665","title":"Expression and function of TrkB variants in developing sensory neurons.","date":"1996","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/8978665","citation_count":99,"is_preprint":false},{"pmid":"8487914","id":"PMC_8487914","title":"BDNF and trkB mRNA expression in the hippocampal formation of aging rats.","date":"1993","source":"Neurobiology of aging","url":"https://pubmed.ncbi.nlm.nih.gov/8487914","citation_count":91,"is_preprint":false},{"pmid":"23380313","id":"PMC_23380313","title":"BDNF-TrkB signaling and neuroprotection in schizophrenia.","date":"2012","source":"Asian journal of psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/23380313","citation_count":90,"is_preprint":false},{"pmid":"30675270","id":"PMC_30675270","title":"Targeting the BDNF/TrkB pathway for the treatment of tumors.","date":"2018","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/30675270","citation_count":86,"is_preprint":false},{"pmid":"34407417","id":"PMC_34407417","title":"A synaptic locus for TrkB signaling underlying ketamine rapid antidepressant action.","date":"2021","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/34407417","citation_count":84,"is_preprint":false},{"pmid":"7789988","id":"PMC_7789988","title":"Cloning and chromosomal localization of the human TRK-B tyrosine kinase receptor gene (NTRK2).","date":"1995","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/7789988","citation_count":81,"is_preprint":false},{"pmid":"22258407","id":"PMC_22258407","title":"Imbalance of neurotrophin receptor isoforms TrkB-FL/TrkB-T1 induces neuronal death in excitotoxicity.","date":"2012","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/22258407","citation_count":80,"is_preprint":false},{"pmid":"32403409","id":"PMC_32403409","title":"Function and Mechanisms of Truncated BDNF Receptor TrkB.T1 in Neuropathic Pain.","date":"2020","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/32403409","citation_count":77,"is_preprint":false},{"pmid":"26004511","id":"PMC_26004511","title":"Slitrk5 Mediates BDNF-Dependent TrkB Receptor Trafficking and Signaling.","date":"2015","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/26004511","citation_count":77,"is_preprint":false},{"pmid":"31377199","id":"PMC_31377199","title":"Targeting BDNF/TrkB pathways for preventing or suppressing epilepsy.","date":"2019","source":"Neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/31377199","citation_count":73,"is_preprint":false},{"pmid":"28230291","id":"PMC_28230291","title":"Therapeutic Potentials of BDNF/TrkB in Breast Cancer; Current Status and Perspectives.","date":"2017","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28230291","citation_count":72,"is_preprint":false},{"pmid":"24982195","id":"PMC_24982195","title":"Neurotrophin receptor TrkB promotes lung adenocarcinoma metastasis.","date":"2014","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/24982195","citation_count":71,"is_preprint":false},{"pmid":"24877631","id":"PMC_24877631","title":"Loss of Ntrk2/Kiss1r signaling in oocytes causes premature ovarian failure.","date":"2014","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/24877631","citation_count":66,"is_preprint":false},{"pmid":"24984919","id":"PMC_24984919","title":"BDNF and its TrkB receptor in human fracture healing.","date":"2014","source":"Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft","url":"https://pubmed.ncbi.nlm.nih.gov/24984919","citation_count":65,"is_preprint":false},{"pmid":"28798343","id":"PMC_28798343","title":"Isoflurane produces antidepressant effects and induces TrkB signaling in rodents.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28798343","citation_count":65,"is_preprint":false},{"pmid":"19357131","id":"PMC_19357131","title":"NTRK1 and NTRK2 receptors facilitate follicle assembly and early follicular development in the mouse ovary.","date":"2009","source":"Reproduction (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/19357131","citation_count":64,"is_preprint":false},{"pmid":"23960204","id":"PMC_23960204","title":"Abnormal retinoid and TrkB signaling in the prefrontal cortex in mood disorders.","date":"2013","source":"Cerebral cortex (New York, N.Y. : 1991)","url":"https://pubmed.ncbi.nlm.nih.gov/23960204","citation_count":64,"is_preprint":false},{"pmid":"16103047","id":"PMC_16103047","title":"The neurotrophic receptor TrkB in anoikis resistance and metastasis: a perspective.","date":"2005","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/16103047","citation_count":63,"is_preprint":false},{"pmid":"17918233","id":"PMC_17918233","title":"Genetic association of neurotrophic tyrosine kinase receptor type 2 (NTRK2) With Alzheimer's disease.","date":"2008","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17918233","citation_count":61,"is_preprint":false},{"pmid":"35321093","id":"PMC_35321093","title":"TrkB Truncated Isoform Receptors as Transducers and Determinants of BDNF Functions.","date":"2022","source":"Frontiers in neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/35321093","citation_count":60,"is_preprint":false},{"pmid":"19018715","id":"PMC_19018715","title":"Association studies of the BDNF and the NTRK2 gene polymorphisms with prophylactic lithium response in bipolar patients.","date":"2008","source":"Pharmacogenomics","url":"https://pubmed.ncbi.nlm.nih.gov/19018715","citation_count":60,"is_preprint":false},{"pmid":"27735126","id":"PMC_27735126","title":"Sulforaphane epigenetically enhances neuronal BDNF expression and TrkB signaling pathways.","date":"2016","source":"Molecular nutrition & food research","url":"https://pubmed.ncbi.nlm.nih.gov/27735126","citation_count":58,"is_preprint":false},{"pmid":"25208620","id":"PMC_25208620","title":"Norepinephrine Protects against Amyloid-β Toxicity via TrkB.","date":"2015","source":"Journal of Alzheimer's disease : JAD","url":"https://pubmed.ncbi.nlm.nih.gov/25208620","citation_count":58,"is_preprint":false},{"pmid":"29499216","id":"PMC_29499216","title":"Brain derived neurotrophic factor (BDNF), its tyrosine kinase receptor B (TrkB) and nicotine.","date":"2018","source":"Neurotoxicology","url":"https://pubmed.ncbi.nlm.nih.gov/29499216","citation_count":55,"is_preprint":false},{"pmid":"32493978","id":"PMC_32493978","title":"Human BDNF/TrkB variants impair hippocampal synaptogenesis and associate with neurobehavioural abnormalities.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/32493978","citation_count":53,"is_preprint":false},{"pmid":"18534558","id":"PMC_18534558","title":"Gene-gene interactions among CHRNA4, CHRNB2, BDNF, and NTRK2 in nicotine dependence.","date":"2008","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/18534558","citation_count":52,"is_preprint":false},{"pmid":"15514702","id":"PMC_15514702","title":"Interaction of BDNF/TrkB signaling with NMDA receptor in learning and memory.","date":"2004","source":"Drug news & perspectives","url":"https://pubmed.ncbi.nlm.nih.gov/15514702","citation_count":49,"is_preprint":false},{"pmid":"32265438","id":"PMC_32265438","title":"TrkB-expressing paraventricular hypothalamic neurons suppress appetite through multiple neurocircuits.","date":"2020","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/32265438","citation_count":49,"is_preprint":false},{"pmid":"33477900","id":"PMC_33477900","title":"The Emerging Role of BDNF/TrkB Signaling in Cardiovascular Diseases.","date":"2021","source":"Life (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/33477900","citation_count":47,"is_preprint":false},{"pmid":"21639804","id":"PMC_21639804","title":"BDNF-TrkB signalling in fear learning: from genetics to neural networks.","date":"2011","source":"Reviews in the neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/21639804","citation_count":44,"is_preprint":false},{"pmid":"32532995","id":"PMC_32532995","title":"A kinase-deficient NTRK2 splice variant predominates in glioma and amplifies several oncogenic signaling pathways.","date":"2020","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/32532995","citation_count":43,"is_preprint":false},{"pmid":"30192229","id":"PMC_30192229","title":"BDNF-TrkB signaling in oxytocin neurons contributes to maternal behavior.","date":"2018","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/30192229","citation_count":43,"is_preprint":false},{"pmid":"23250006","id":"PMC_23250006","title":"Prelimbic BDNF and TrkB signaling regulates consolidation of both appetitive and aversive emotional learning.","date":"2012","source":"Translational psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/23250006","citation_count":43,"is_preprint":false},{"pmid":"26200505","id":"PMC_26200505","title":"BDNF, via truncated TrkB receptor, modulates GlyT1 and GlyT2 in astrocytes.","date":"2015","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/26200505","citation_count":41,"is_preprint":false},{"pmid":"35973996","id":"PMC_35973996","title":"A TrkB agonist prodrug prevents bone loss via inhibiting asparagine endopeptidase and increasing osteoprotegerin.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/35973996","citation_count":39,"is_preprint":false},{"pmid":"30477984","id":"PMC_30477984","title":"Prefrontal cortical trkB, glucocorticoids, and their interactions in stress and developmental contexts.","date":"2018","source":"Neuroscience and biobehavioral reviews","url":"https://pubmed.ncbi.nlm.nih.gov/30477984","citation_count":38,"is_preprint":false},{"pmid":"26517952","id":"PMC_26517952","title":"Role of TrkB kinase activity in aging diaphragm neuromuscular junctions.","date":"2015","source":"Experimental gerontology","url":"https://pubmed.ncbi.nlm.nih.gov/26517952","citation_count":36,"is_preprint":false},{"pmid":"22752556","id":"PMC_22752556","title":"RNA aptamer-based functional ligands of the neurotrophin receptor, TrkB.","date":"2012","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/22752556","citation_count":36,"is_preprint":false},{"pmid":"38433044","id":"PMC_38433044","title":"TrkB transmembrane domain: bridging structural understanding with therapeutic strategy.","date":"2024","source":"Trends in biochemical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/38433044","citation_count":34,"is_preprint":false},{"pmid":"35269763","id":"PMC_35269763","title":"The BDNF/TrkB Neurotrophin System in the Sensory Organs of Zebrafish.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35269763","citation_count":34,"is_preprint":false},{"pmid":"18479217","id":"PMC_18479217","title":"Targeting TrkB neurotrophin receptor to treat depression.","date":"2008","source":"Expert opinion on therapeutic targets","url":"https://pubmed.ncbi.nlm.nih.gov/18479217","citation_count":34,"is_preprint":false},{"pmid":"24069289","id":"PMC_24069289","title":"The interaction of BDNF and NTRK2 gene increases the susceptibility of paranoid schizophrenia.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24069289","citation_count":33,"is_preprint":false},{"pmid":"26657794","id":"PMC_26657794","title":"TrkB Promotes Breast Cancer Metastasis via Suppression of Runx3 and Keap1 Expression.","date":"2015","source":"Molecules and cells","url":"https://pubmed.ncbi.nlm.nih.gov/26657794","citation_count":33,"is_preprint":false},{"pmid":"29186135","id":"PMC_29186135","title":"Regulation of actions and habits by ventral hippocampal trkB and adolescent corticosteroid exposure.","date":"2017","source":"PLoS biology","url":"https://pubmed.ncbi.nlm.nih.gov/29186135","citation_count":33,"is_preprint":false},{"pmid":"23315174","id":"PMC_23315174","title":"Neurotrophic tyrosine kinase receptor type 2 (NTRK2) gene associated with treatment response to mood stabilizers in patients with bipolar I disorder.","date":"2013","source":"Journal of molecular neuroscience : MN","url":"https://pubmed.ncbi.nlm.nih.gov/23315174","citation_count":32,"is_preprint":false},{"pmid":"31470106","id":"PMC_31470106","title":"TrkB agonistic antibodies superior to BDNF: Utility in treating motoneuron degeneration.","date":"2019","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/31470106","citation_count":32,"is_preprint":false},{"pmid":"30637517","id":"PMC_30637517","title":"TrkB neurotrophin receptor at the core of antidepressant effects, but how?","date":"2019","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/30637517","citation_count":31,"is_preprint":false},{"pmid":"36266274","id":"PMC_36266274","title":"A BDNF-TrkB autocrine loop enhances senescent cell viability.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/36266274","citation_count":30,"is_preprint":false},{"pmid":"36064939","id":"PMC_36064939","title":"The MBNL1/circNTRK2/PAX5 pathway regulates aerobic glycolysis in glioblastoma cells by encoding a novel protein NTRK2-243aa.","date":"2022","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/36064939","citation_count":29,"is_preprint":false},{"pmid":"39030441","id":"PMC_39030441","title":"BDNF-TrkB Signaling in Mitochondria: Implications for Neurodegenerative Diseases.","date":"2024","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/39030441","citation_count":29,"is_preprint":false},{"pmid":"32277855","id":"PMC_32277855","title":"Cholinergic neuroplasticity in asthma driven by TrkB signaling.","date":"2020","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/32277855","citation_count":29,"is_preprint":false},{"pmid":"10077331","id":"PMC_10077331","title":"Compartmental expression of trkB receptor protein in the developing striatum.","date":"1999","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/10077331","citation_count":28,"is_preprint":false},{"pmid":"33434621","id":"PMC_33434621","title":"ERRγ ligand HPB2 upregulates BDNF-TrkB and enhances dopaminergic neuronal phenotype.","date":"2021","source":"Pharmacological research","url":"https://pubmed.ncbi.nlm.nih.gov/33434621","citation_count":27,"is_preprint":false},{"pmid":"21739244","id":"PMC_21739244","title":"Expression of TrkB and BDNF in human cochlea-an immunohistochemical study.","date":"2011","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/21739244","citation_count":26,"is_preprint":false},{"pmid":"32775002","id":"PMC_32775002","title":"LMP1 promotes nasopharyngeal carcinoma metastasis through NTRK2-mediated anoikis resistance.","date":"2020","source":"American journal of cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/32775002","citation_count":26,"is_preprint":false},{"pmid":"29408225","id":"PMC_29408225","title":"Partial TrkB receptor activation suppresses cortical epileptogenesis through actions on parvalbumin interneurons.","date":"2018","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/29408225","citation_count":26,"is_preprint":false},{"pmid":"25502751","id":"PMC_25502751","title":"The truncated TrkB receptor influences mammalian sleep.","date":"2014","source":"American journal of physiology. Regulatory, integrative and comparative physiology","url":"https://pubmed.ncbi.nlm.nih.gov/25502751","citation_count":25,"is_preprint":false},{"pmid":"32366954","id":"PMC_32366954","title":"Individual differences in stereotypy and neuron subtype translatome with TrkB deletion.","date":"2020","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/32366954","citation_count":24,"is_preprint":false},{"pmid":"25710496","id":"PMC_25710496","title":"The neurotrophic receptor Ntrk2 directs lymphoid tissue neovascularization during Leishmania donovani infection.","date":"2015","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/25710496","citation_count":23,"is_preprint":false},{"pmid":"36233065","id":"PMC_36233065","title":"Enhanced BDNF and TrkB Activation Enhance GABA Neurotransmission in Cerebellum in Hyperammonemia.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36233065","citation_count":23,"is_preprint":false},{"pmid":"39046880","id":"PMC_39046880","title":"BDNF-TrkB signaling orchestrates the buildup process of local sleep.","date":"2024","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/39046880","citation_count":23,"is_preprint":false},{"pmid":"33593856","id":"PMC_33593856","title":"Adult trkB Signaling in Parvalbumin Interneurons is Essential to Prefrontal Network Dynamics.","date":"2021","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/33593856","citation_count":23,"is_preprint":false},{"pmid":"35383130","id":"PMC_35383130","title":"Circular RNA_0006014 promotes breast cancer progression through sponging miR-885-3p to regulate NTRK2 and PIK3/AKT pathway.","date":"2022","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/35383130","citation_count":22,"is_preprint":false},{"pmid":"30362154","id":"PMC_30362154","title":"P2X4R silence suppresses glioma cell growth through BDNF/TrkB/ATF4 signaling pathway.","date":"2018","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30362154","citation_count":22,"is_preprint":false},{"pmid":"39304417","id":"PMC_39304417","title":"Rethinking the role of TRKB in the action of antidepressants and psychedelics.","date":"2024","source":"Trends in neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/39304417","citation_count":21,"is_preprint":false},{"pmid":"32936344","id":"PMC_32936344","title":"Local TrkB signaling: themes in development and neural plasticity.","date":"2020","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/32936344","citation_count":21,"is_preprint":false},{"pmid":"35721318","id":"PMC_35721318","title":"Transactivation of TrkB Receptors by Oxytocin and Its G Protein-Coupled Receptor.","date":"2022","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/35721318","citation_count":21,"is_preprint":false},{"pmid":"18405896","id":"PMC_18405896","title":"Expression and localisation of BDNF, NT4 and TrkB in proliferative vitreoretinopathy.","date":"2008","source":"Experimental eye research","url":"https://pubmed.ncbi.nlm.nih.gov/18405896","citation_count":21,"is_preprint":false},{"pmid":"15389758","id":"PMC_15389758","title":"Association study of neurotrophic tyrosine kinase receptor type 2 (NTRK2) and childhood-onset mood disorders.","date":"2005","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15389758","citation_count":21,"is_preprint":false},{"pmid":"32193501","id":"PMC_32193501","title":"Effects of palmatine on BDNF/TrkB-mediated trigeminal neuralgia.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/32193501","citation_count":20,"is_preprint":false},{"pmid":"24903749","id":"PMC_24903749","title":"Antiseizure effects of TrkB kinase inhibition.","date":"2014","source":"Epilepsia","url":"https://pubmed.ncbi.nlm.nih.gov/24903749","citation_count":20,"is_preprint":false},{"pmid":"32427585","id":"PMC_32427585","title":"TrkB agonists prevent postischemic emergence of refractory neonatal seizures in mice.","date":"2020","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/32427585","citation_count":20,"is_preprint":false},{"pmid":"36533776","id":"PMC_36533776","title":"Tropomyosin receptor kinase B (TrkB) signalling: targeted therapy in neurogenic tumours.","date":"2022","source":"The journal of pathology. Clinical research","url":"https://pubmed.ncbi.nlm.nih.gov/36533776","citation_count":19,"is_preprint":false},{"pmid":"38254691","id":"PMC_38254691","title":"Genetic Dissection of BDNF and TrkB Expression in Glial Cells.","date":"2024","source":"Biomolecules","url":"https://pubmed.ncbi.nlm.nih.gov/38254691","citation_count":19,"is_preprint":false},{"pmid":"31678045","id":"PMC_31678045","title":"Locally Activating TrkB Receptor Generates Actin Waves and Specifies Axonal Fate.","date":"2019","source":"Cell chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/31678045","citation_count":19,"is_preprint":false},{"pmid":"34298123","id":"PMC_34298123","title":"Stress Diminishes BDNF-stimulated TrkB Signaling, TrkB-NMDA Receptor Linkage and Neuronal Activity in the Rat Brain.","date":"2021","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/34298123","citation_count":19,"is_preprint":false},{"pmid":"28205449","id":"PMC_28205449","title":"Variations in COMT and NTRK2 Influence Symptom Burden in Women Undergoing Breast Cancer Treatment.","date":"2017","source":"Biological research for nursing","url":"https://pubmed.ncbi.nlm.nih.gov/28205449","citation_count":19,"is_preprint":false},{"pmid":"22425982","id":"PMC_22425982","title":"Evidence that truncated TrkB isoform, TrkB-Shc can regulate phosphorylated TrkB protein levels.","date":"2012","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/22425982","citation_count":19,"is_preprint":false},{"pmid":"32422149","id":"PMC_32422149","title":"Optical Activation of TrkB Signaling.","date":"2020","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/32422149","citation_count":18,"is_preprint":false},{"pmid":"27494324","id":"PMC_27494324","title":"Prenatal Cocaine Exposure Upregulates BDNF-TrkB Signaling.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/27494324","citation_count":18,"is_preprint":false},{"pmid":"29540698","id":"PMC_29540698","title":"Bidirectional coordination of actions and habits by TrkB in mice.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29540698","citation_count":18,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":46896,"output_tokens":8494,"usd":0.134049,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":18202,"output_tokens":6535,"usd":0.127192,"stage2_stop_reason":"end_turn"},"total_usd":0.261241,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1989,\n      \"finding\": \"trkB encodes a novel glycoprotein receptor tyrosine kinase (gp145trkB) with a 145 kDa molecular weight (93 kDa polypeptide backbone), expressed preferentially in brain and nervous system tissues, identifying it as a cell surface receptor in the tyrosine kinase family.\",\n      \"method\": \"cDNA cloning, glycoprotein synthesis from biologically active cDNA, in situ hybridization\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — original biochemical characterization with cDNA reconstitution, molecular weight determination, and expression analysis; foundational paper replicated extensively\",\n      \"pmids\": [\"2555172\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"The trkB tyrosine kinase receptor serves as a functional receptor for neurotrophin-4 (NT-4/XNT-4): XNT-4 displaces 125I-BDNF from gp145trkB, induces tyrosine phosphorylation, causes NIH 3T3 transformation when co-expressed with gp145trkB, and induces PC12 neuronal differentiation. Mutation of extracellular Cys-345 to Ser abolishes XNT-4 activation but not BDNF activation, indicating partially distinct binding domains for NT-4 and BDNF on TrkB.\",\n      \"method\": \"Radioligand displacement assay (125I-BDNF), tyrosine phosphorylation assay, NIH 3T3 transformation assay, PC12 differentiation assay, site-directed mutagenesis (Cys345Ser)\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal in vitro assays plus mutagenesis identifying distinct ligand contact residues in a single study\",\n      \"pmids\": [\"1375038\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"In neuroblastoma cells (SMS-KCN) co-expressing TrkB and BDNF, exogenous BDNF induces tyrosine phosphorylation of TrkB and activates downstream phospholipase C-γ1, ERK1/2, and PI3K; BDNF also induces immediate-early genes c-FOS and NGFI-A and promotes cell survival and neurite outgrowth, constituting an autocrine/paracrine survival loop.\",\n      \"method\": \"Tyrosine phosphorylation assay (immunoblot), downstream kinase activation assays, immediate-early gene expression, cell survival and neurite outgrowth assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple downstream signaling readouts in a cell line with BDNF stimulation; single lab\",\n      \"pmids\": [\"8264643\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Non-catalytic (truncated) TrkB isoforms act as dominant-negative receptors: co-expression of non-catalytic TrkB with catalytic TrkB in NGF-dependent sympathetic neurons substantially reduces BDNF-mediated survival signaling, demonstrating that the relative levels of catalytic vs. non-catalytic TrkB isoforms modulate BDNF responsiveness.\",\n      \"method\": \"Plasmid injection into neurons, survival assay, manipulation of TrkB isoform expression ratios\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct functional assay in primary neurons with isoform co-expression; single lab\",\n      \"pmids\": [\"8978665\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"TrkB is required for maturation and synaptogenesis of hippocampal connections in vivo: trkB(-/-) mice show reduced axon collaterals (21-49%), decreased axonal varicosity density, lower synaptic contact density, altered presynaptic bouton ultrastructure (decreased synaptic vesicle density), and reduced expression of v-SNARE and t-SNARE synaptic proteins, demonstrating TrkB is essential for presynaptic development.\",\n      \"method\": \"Lipophilic tracer injections, biocytin fills, electron microscopy, immunocytochemistry, knockout mouse analysis\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (tract tracing, EM, immunocytochemistry) in genetic knockout mice\",\n      \"pmids\": [\"9736654\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"TrkB mediates hippocampal LTP via recruitment of PLCγ and subsequent phosphorylation of CaMKIV and CREB: mice with targeted mutation in the PLCγ docking site of TrkB (trkB(PLC/PLC)) show impaired hippocampal LTP and strongly reduced CaMKIV/CREB phosphorylation upon BDNF stimulation, while MAPK activation is retained. Mice with mutated Shc docking site (trkB(SHC/SHC)) retain LTP but show impaired MAPK activation, indicating parallel signaling pathways.\",\n      \"method\": \"Targeted knockin mutagenesis (PLCγ and Shc docking site mutations), electrophysiology (LTP recording), BDNF-stimulated signaling assays (pCaMKIV, pCREB, pMAPK) in primary neurons\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — genetic knockin mutagenesis combined with electrophysiology and biochemical signaling assays; widely replicated/cited\",\n      \"pmids\": [\"12367511\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"TrkB suppresses anoikis (detachment-induced apoptosis) in non-malignant epithelial cells by activating the PI3K/PKB (Akt) pathway, enabling cell survival and proliferation in suspension and promoting metastasis in mice. TrkB-expressing cells formed rapidly growing tumors that infiltrated lymphatics and blood vessels.\",\n      \"method\": \"Genome-wide functional screen for anoikis suppression, PI3K/Akt pathway inhibition assays, mouse tumor formation and metastasis assays\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — functional screen plus defined pathway (PI3K/Akt) plus in vivo metastasis model; published in high-impact journal with extensive replication\",\n      \"pmids\": [\"15329723\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"NTRK2 (TrkB) and NTRK1 receptors are required for timely primordial follicle assembly and early follicular development in the mouse ovary; Ntrk2(-/-) mice show reduced follicle assembly and decreased FSH receptor (FSHR) expression. NT-4 (NTF4) exposure increases Fshr gene expression and cyclin D2 formation, indicating TrkB signaling induces functional FSHR to facilitate subsequent follicle development.\",\n      \"method\": \"Knockout mouse analysis (Ntrk2(-/-)), follicle counting, FSHR expression assay, NTF4 treatment of ovaries, cyclin D2 formation assay\",\n      \"journal\": \"Reproduction (Cambridge, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic knockout with multiple readouts; single lab\",\n      \"pmids\": [\"19357131\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Excitotoxicity causes neuronal death via imbalance of TrkB isoforms: calpain cleaves full-length TrkB (TrkB-FL) producing a truncated form similar to inactive TrkB-T1, while mRNA of TrkB-T1 is upregulated. Restoring TrkB-FL/TrkB-T1 balance via lentiviral TrkB-T1 interference and TrkB-FL overexpression protects neurons from excitotoxic death.\",\n      \"method\": \"Calpain cleavage assay, Western blot, RT-PCR, lentiviral gene delivery (TrkB-T1 knockdown + TrkB-FL overexpression), excitotoxicity neuronal survival assay, stroke patient tissue analysis\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mechanistic cleavage identified biochemically plus functional rescue with lentiviral intervention; single lab\",\n      \"pmids\": [\"22258407\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"TrkB-Shc truncated isoform reduces phosphorylated full-length TrkB (TrkB-TK+) protein levels in response to BDNF, suggesting TrkB-Shc promotes degradation of activated TrkB-TK+ complexes to prevent TrkB overactivation; conversely, TrkB-Shc protein stability is increased following BDNF exposure.\",\n      \"method\": \"Transient overexpression in CHOK1 cells, BDNF stimulation, immunoblot for phospho-TrkB and TrkB isoform protein levels\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, overexpression in non-neuronal cells, single method (Western blot)\",\n      \"pmids\": [\"22425982\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Oligodendrocyte-specific TrkB deletion disrupts myelination: conditional TrkB knockout in oligodendrocytes reduces myelin protein expression and myelin thickness in CNS white matter tracts during development without affecting the number of mature oligodendrocytes or myelinated axons, demonstrating a direct role for TrkB in myelin ensheathment. TrkB deletion in oligodendroglia also increases OPC proliferation, an effect dependent on TrkC and p75 expression.\",\n      \"method\": \"Conditional knockout mice (oligodendrocyte-specific TrkB deletion), myelin protein expression assay, electron microscopy for myelin thickness, OPC density quantification, in vitro TrkB knockdown in OPCs\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cell-type specific conditional knockout with multiple orthogonal readouts (protein expression, EM, cell counting, in vitro validation)\",\n      \"pmids\": [\"23486965\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Retinoic acid receptor α (RARα) binds to and transactivates the TrkB promoter via a putative retinoic acid response element, providing a transcriptional mechanism by which retinoid signaling upregulates TrkB expression.\",\n      \"method\": \"In vitro transcription/promoter binding assay, chromatin immunoprecipitation/reporter assay for RARα binding to TrkB promoter\",\n      \"journal\": \"Cerebral cortex\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, single method (promoter transactivation), not independently replicated\",\n      \"pmids\": [\"23960204\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Oocyte-specific deletion of Ntrk2 causes post-pubertal oocyte death and infertility. Oocytes lacking NTRK2 fail to activate PI3K-AKT signaling in response to gonadotropins. The preovulatory gonadotropin surge rapidly induces full-length NTRK2 (NTRK2.FL) expression in oocytes, and BDNF + kisspeptin act cooperatively (via oocyte NTRK2.T1 and KISS1R) to mediate gonadotropin-induced NTRK2.FL upregulation, establishing NTRK2-AKT as the survival pathway activated at the onset of reproductive cyclicity.\",\n      \"method\": \"Oocyte-specific conditional knockout (Ntrk2), gonadotropin stimulation assays, PI3K-AKT activation assays, cell line co-expression of NTRK2.T1 + KISS1R with BDNF/kisspeptin stimulation\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional knockout with multiple cellular and molecular readouts; cooperative ligand signaling established in cell line\",\n      \"pmids\": [\"24877631\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Slitrk5 directly interacts with TrkB receptors and mediates BDNF-dependent TrkB trafficking: under basal conditions Slitrk5 preferentially binds PTPδ, but upon BDNF stimulation, Slitrk5 shifts to cis-interactions with TrkB. Absence of Slitrk5 reduces ligand-dependent TrkB recycling and alters BDNF responsiveness. Slitrk5 recruits the Rab11 effector Rab11-FIP3 to direct TrkB to Rab11-positive recycling endosomes.\",\n      \"method\": \"Co-immunoprecipitation, structured illumination microscopy, receptor recycling assays, Rab11-FIP3 pulldown, Slitrk5 knockout mouse analysis\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP, super-resolution microscopy, receptor recycling assays, and genetic knockout in one study; multiple orthogonal methods\",\n      \"pmids\": [\"26004511\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"BDNF acting via truncated TrkB-T1 (not full-length TrkB-FL) promotes internalization of glycine transporters GlyT1 and GlyT2 in astrocytes through Rho-GTPase signaling: BDNF decreases Vmax but not Km of glycine transport (consistent with transporter internalization); dynasore (dynamin/clathrin inhibitor) prevents this effect; Rho-family blocker (toxin B) and TrkB-T knockdown abolish it, while PLCγ, PI3K, and MAPK inhibitors do not.\",\n      \"method\": \"Radiolabeled glycine transport assay ([3H]glycine), pharmacological inhibitors, RNAi (TrkB-T knockdown), immunofluorescence for transporter endosomal localization\",\n      \"journal\": \"Glia\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple pharmacological and RNAi approaches in primary astrocytes; single lab\",\n      \"pmids\": [\"26200505\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Local TrkB activation at neurite ends initiates actin waves and specifies axonal fate: optogenetic activation (Opto-cytTrkB) of TrkB signaling in the distal neurite triggers F-actin wave generation from the somato-neuritic area toward the neurite end; TrkB signaling connects distally activated Rac1 to proximal signaling pathways; local TrkB activation relocates the axon initial segment organizer ankyrinG and confers axonal identity to the stimulated neurite.\",\n      \"method\": \"Optogenetics (Opto-cytTrkB), live imaging of actin waves, immunostaining for ankyrinG, Rac1 activity assays\",\n      \"journal\": \"Cell chemical biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — optogenetic spatial activation with live imaging and molecular markers; novel approach but single lab\",\n      \"pmids\": [\"31678045\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"A truncated NTRK2 splice variant TrkB.T1 (kinase-deficient) enhances PDGF-driven gliomas in vivo and augments PDGF-induced Akt and STAT3 signaling in vitro in a ligand-independent fashion; next-generation sequencing broadly implicates TrkB.T1 in PI3K signaling cascades.\",\n      \"method\": \"In vivo glioma model (PDGF-driven), in vitro Akt/STAT3 signaling assays, next-generation sequencing, splice variant characterization\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo tumor model combined with in vitro signaling assays; single lab with multiple readouts\",\n      \"pmids\": [\"32532995\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"TrkB-expressing paraventricular hypothalamic (PVH) neurons suppress appetite through multiple neurocircuits: selective Ntrk2 deletion in PVH causes severe hyperphagic obesity; PVHTrkB neurons project to both VMH and LPBN; Ntrk2 deletion in either projection causes hyperphagia and obesity; BDNF increases firing of PVHTrkB neurons, demonstrating TrkB as a key regulator of PVH appetite circuits.\",\n      \"method\": \"Conditional Ntrk2 knockout (PVH-specific), chemogenetic activation/inhibition (DREADD), axonal projection tracing, electrophysiology, BDNF stimulation\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional knockout, chemogenetics, circuit tracing, and electrophysiology combined in one study\",\n      \"pmids\": [\"32265438\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Both typical and fast-acting antidepressants directly bind to the transmembrane domain (TMD) of TrkB dimers, facilitating synaptic TrkB localization and its activation by BDNF. The TMD of TrkB has a cholesterol-sensing function mediating synaptic effects of cholesterol. Mutation of the TrkB antidepressant-binding motif impairs cellular, behavioral, and plasticity-promoting responses to antidepressants in vitro and in vivo. Atomistic molecular dynamics simulations defined the binding site at the TMD of TrkB dimers.\",\n      \"method\": \"Molecular dynamics simulations, radioligand binding assays, site-directed mutagenesis of antidepressant-binding motif, synaptic localization assays, in vitro and in vivo behavioral/plasticity assays\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — computational structure prediction validated by mutagenesis, binding assays, and in vivo functional experiments; multiple orthogonal methods\",\n      \"pmids\": [\"33606976\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Postsynaptic TrkB in CA1 neurons is required for ketamine-induced synaptic potentiation and rapid antidepressant action: deletion of TrkB only in CA1 (postsynaptic) but not CA3 (presynaptic) eliminates ketamine-induced synaptic potentiation; ketamine elicits dynamin1-dependent TrkB activation and downstream signaling.\",\n      \"method\": \"Region-specific BDNF/TrkB deletion (CA3 vs CA1), electrophysiology (synaptic potentiation), dynamin1 dependence assay, behavioral antidepressant assay\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cell-type specific conditional deletion with electrophysiology and behavioral readouts; dynamin1-dependence mechanistically links TrkB trafficking to ketamine's action\",\n      \"pmids\": [\"34407417\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"BDNF and TrkB form an autocrine loop in senescent cells: senescent cells express high TrkB (NTRK2) and secrete BDNF (SASP factor); TrkB activation by BDNF promotes senescent cell survival by activating ERK5 and elevating BCL2L2; TrkB inhibition selectively triggers apoptosis of senescent cells and reduces senescent cell accumulation in aged mouse organs.\",\n      \"method\": \"Drug library screen, TrkB inhibitor treatment, BDNF ablation, ERK5/BCL2L2 signaling assays, apoptosis assays, in vivo aged mouse organ analysis\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — drug screen plus mechanistic dissection (ERK5, BCL2L2) plus in vivo validation in aged mice; multiple orthogonal methods\",\n      \"pmids\": [\"36266274\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Oxytocin rapidly transactivates TrkB receptors in primary cortical neurons and in acute brain slices, increasing TrkB tyrosine phosphorylation via the oxytocin GPCR (not the vasopressin receptor). TrkB transactivation by oxytocin enhances gephyrin clustering, suggesting a mechanism for oxytocin modulation of inhibitory synapses.\",\n      \"method\": \"Immunoblot for phospho-TrkB, acute brain slice preparation (bath application), primary cortical culture, receptor pharmacology, gephyrin clustering immunostaining\",\n      \"journal\": \"Frontiers in molecular neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — biochemical phosphorylation assays in primary neurons and acute slices with pharmacological dissection; single lab\",\n      \"pmids\": [\"35721318\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"TrkB activation via BDNF/TrkB signaling activates Akt which phosphorylates and inhibits asparagine endopeptidase (AEP); TrkB agonist R13 increases osteoprotegerin (OPG) through TrkB→CREB activation, blocking trabecular bone loss; TrkB also inhibits the C/EBPβ/AEP pathway to suppress RANKL-induced osteoclastogenesis.\",\n      \"method\": \"TrkB agonist (R13/7,8-DHF) treatment, ovariectomy (OVX) mouse model, AEP knockout mice, AEP phosphorylation assays, OPG/RANKL measurement, osteoclastogenesis assay (RAW264.7), CREB activation assay\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological and genetic (AEP KO, OVX) approaches with multiple molecular readouts; single lab\",\n      \"pmids\": [\"35973996\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"LSD and psilocin directly bind to TrkB with affinities ~1,000-fold higher than other antidepressants, binding at distinct but partially overlapping sites within the TMD of TrkB dimers relative to antidepressant binding sites. Psychedelic effects on neurotrophic signaling, plasticity, and antidepressant-like behavior depend on TrkB binding and promotion of endogenous BDNF signaling but are independent of 5-HT2A receptor activation; LSD-induced head twitching is dependent on 5-HT2A and independent of TrkB.\",\n      \"method\": \"Radioligand binding assays, molecular dynamics simulations, TrkB-binding site mutagenesis, neurotrophic signaling assays, plasticity assays, in vivo behavioral assays in mice (antidepressant-like behavior, head twitch response)\",\n      \"journal\": \"Nature neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — binding assays, mutagenesis, and multiple in vivo behavioral experiments; mechanistically dissects TrkB from 5-HT2A contributions\",\n      \"pmids\": [\"37280397\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Cortical BDNF-TrkB-CREB signaling in layer 5 pyramidal neurons regulates sleep slow-wave activity (SWA): pharmacological and optogenetic perturbations show TrkB activation is required for SWA buildup; TrkB activation enriches ubiquitin and proteasome subunits (by proteomic analysis); BDNF effects on synaptic strength increase SWA independently of neuronal firing per se.\",\n      \"method\": \"Pharmacology (TrkB inhibitor), optogenetic perturbations, EEG (SWA measurement), RNA sequencing/transcriptomics, proteomics, mathematical modeling, layer 5 cell-specific analysis\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological and optogenetic interventions with electrophysiology and proteomics; localization to L5 neurons; single lab\",\n      \"pmids\": [\"39046880\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"BDNF-TrkB signaling in oxytocin (OXT) neurons is required for maternal behavior: ablation of TrkB selectively in OXT neurons partially recapitulates maternal care impairments seen in BDNF-deficient females; BDNF signaling through TrkB in OXT neurons regulates oxytocin expression during development.\",\n      \"method\": \"OXT neuron-specific TrkB conditional knockout, maternal behavior assessment, oxytocin expression analysis, translating ribosome affinity purification (TRAP) RNA-seq\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-type specific conditional knockout with behavioral and molecular readouts; single lab\",\n      \"pmids\": [\"30192229\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Adult TrkB signaling in parvalbumin (PV) interneurons of the medial prefrontal cortex is essential for maintenance of PV interneuron integrity, local network dynamics, and γ oscillations: viral dominant-negative trkB expression in mPFC PV interneurons reduces PV inhibition, increases broadband LFP activity, and increases aggression, demonstrating that adult BDNF/trkB signaling sustains PV interneuron function.\",\n      \"method\": \"Viral vector (dominant-negative trkB), immunohistochemistry, local field potential (LFP) recording, behavioral assays\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — viral dominant-negative approach in specific cell type with electrophysiology and behavior; single lab\",\n      \"pmids\": [\"33593856\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Overexpression of truncated (inactive) TrkB in the orbitofrontal cortex or dorsomedial striatum interferes with TrkB phosphorylation and ERK42/44 phosphorylation, abolishing goal-directed action selection. In the dorsolateral striatum, truncated TrkB overexpression blocks habit formation, demonstrating that corticostriatal TrkB-ERK signaling is necessary for balancing goal-directed versus habitual behaviors.\",\n      \"method\": \"Viral-mediated truncated TrkB overexpression in specific brain regions, immunoblot for phospho-TrkB and phospho-ERK, operant conditioning behavioral assays\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — region-specific viral intervention with signaling assays and behavioral readouts; single lab\",\n      \"pmids\": [\"29540698\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"TrkB kinase activity at neuromuscular junctions (NMJ) is required for presynaptic terminal maintenance: inhibition of TrkB kinase activity in TrkBF616A mice reduces presynaptic terminal volume (~20%) and motor end-plate area (~10%); in early old age, TrkB kinase inhibition significantly reduces NMJ pre/postsynaptic overlap and increases denervated NMJs (~20%).\",\n      \"method\": \"Chemical-genetic TrkB kinase inhibition (TrkBF616A + 1NMPP1), confocal microscopy of NMJ morphology, quantification of denervation\",\n      \"journal\": \"Experimental gerontology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — chemical-genetic approach with defined structural readouts at NMJ; single lab\",\n      \"pmids\": [\"26517952\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"TrkB kinase activity inhibition suppresses kindled seizures: inducible conditional TrkB knockout reduces behavioral seizure severity; chemical-genetic TrkB kinase inhibition (TrkBF616A + 1NMPP1) reversibly elevates focal electrographic and generalized seizure thresholds in kindled mice, establishing TrkB kinase as an antiseizure target.\",\n      \"method\": \"Inducible conditional TrkB knockout (Act-CreER TrkBflox/flox), chemical-genetic approach (TrkBF616A + 1NMPP1), kindling model, electrographic seizure threshold measurement\",\n      \"journal\": \"Epilepsia\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — two independent genetic approaches (conditional KO and chemical-genetic) with electrophysiology in same model\",\n      \"pmids\": [\"24903749\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"RNA aptamer C4-3 binds the extracellular domain of TrkB with high affinity (Kd ~2 nM), acts as a partial TrkB agonist, exhibits neuroprotective effects in cortical neurons, and activates TrkB upon hippocampal infusion in mice, demonstrating the extracellular domain as a functional binding/activation site.\",\n      \"method\": \"Recombinant protein binding assays (Kd measurement), cell-based signaling assays, cortical neuron neuroprotection assay, in vivo TrkB activation (hippocampal infusion)\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple binding and functional assays in vitro and in vivo; single lab\",\n      \"pmids\": [\"22752556\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NTRK2 (TrkB) is a transmembrane receptor tyrosine kinase that is activated by BDNF, NT-4, and NT-3; upon ligand binding, TrkB undergoes autophosphorylation and recruits PLCγ (required for hippocampal LTP via CaMKIV/CREB), Shc/MAPK, and PI3K/Akt signaling cascades; antidepressants and psychedelics directly bind its transmembrane domain to allosterically potentiate BDNF signaling; TrkB also mediates cholesterol-dependent synaptic localization, is transactivated by oxytocin GPCRs, and its kinase-deficient truncated isoform TrkB.T1 modulates full-length TrkB activity through dominant-negative effects, regulates glycine transporter internalization via Rho-GTPase, and promotes senescent cell survival via ERK5/BCL2L2; circuit-level, TrkB in paraventricular hypothalamic neurons suppresses appetite, in CA1 postsynaptic neurons mediates ketamine's rapid antidepressant effects, and in parvalbumin interneurons maintains prefrontal network dynamics.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"NTRK2 (TrkB) is a brain-enriched transmembrane glycoprotein receptor tyrosine kinase that transduces neurotrophin signals to control neuronal survival, synaptic plasticity, and circuit-level behavior [#0, #2]. It is activated by BDNF and by NT-4/NT-4, which engage partially distinct extracellular contact residues, triggering receptor autophosphorylation and recruitment of downstream effectors [#1]. Ligand binding bifurcates into parallel cascades whose physiological outputs are separable: phosphorylation of a PLC\\u03b3 docking site drives CaMKIV/CREB activation required for hippocampal LTP, whereas a distinct Shc docking site couples to MAPK, and a PI3K/Akt arm supports survival and anti-apoptotic signaling [#5, #6]. Through these outputs TrkB is essential for presynaptic maturation and synaptogenesis of hippocampal connections [#4], oligodendrocyte myelin ensheathment [#10], and the integrity of prefrontal parvalbumin interneuron network dynamics [#26]; at the circuit level it acts in paraventricular hypothalamic neurons to suppress appetite [#17] and in postsynaptic CA1 neurons to mediate ketamine's rapid antidepressant effect via dynamin1-dependent activation [#19]. TrkB receptor availability is shaped by its truncated, kinase-deficient isoforms (TrkB.T1/TrkB-Shc), which act as dominant-negative modulators of full-length receptor responsiveness and can signal independently to drive glycine transporter internalization and tumor-promoting PI3K/Akt-STAT3 output [#3, #15, #16], and by Slitrk5-directed recycling through Rab11 endosomes [#13]. Beyond canonical neurotrophins, TrkB is transactivated by oxytocin GPCR signaling [#21] and is directly bound at its transmembrane domain by antidepressants and psychedelics, which allosterically potentiate BDNF signaling in a cholesterol-sensitive manner [#18, #23]. TrkB function also extends to ovarian follicle and oocyte survival via PI3K-AKT [#12], senescent-cell survival via an autocrine BDNF loop activating ERK5/BCL2L2 [#20], and bone homeostasis [#22], and TrkB kinase activity is an antiseizure target [#29].\",\n  \"teleology\": [\n    {\n      \"year\": 1989,\n      \"claim\": \"Established the molecular identity of TrkB as a nervous-system-enriched receptor tyrosine kinase, defining the protein class whose ligands and signaling would later be dissected.\",\n      \"evidence\": \"cDNA cloning and glycoprotein reconstitution with in situ hybridization\",\n      \"pmids\": [\"2555172\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify the activating ligand\", \"No downstream signaling defined\"]\n    },\n    {\n      \"year\": 1992,\n      \"claim\": \"Identified NT-4 as a TrkB ligand and showed via Cys345Ser mutagenesis that NT-4 and BDNF use partially distinct contact residues, revealing ligand-selective receptor engagement.\",\n      \"evidence\": \"Radioligand displacement, tyrosine phosphorylation, transformation/differentiation assays, site-directed mutagenesis\",\n      \"pmids\": [\"1375038\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not map the full ligand-binding interface\", \"NT-3 contribution not addressed here\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Connected TrkB activation to a defined set of downstream effectors (PLC\\u03b31, ERK1/2, PI3K) and survival/differentiation outputs, framing TrkB as a multi-pathway survival receptor.\",\n      \"evidence\": \"Phospho-immunoblots and downstream activation/survival assays in BDNF-expressing neuroblastoma cells\",\n      \"pmids\": [\"8264643\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single cell line, single lab\", \"Did not establish which pathway controls which phenotype\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Showed truncated TrkB isoforms act as dominant-negative receptors, establishing that the catalytic/non-catalytic isoform ratio tunes BDNF responsiveness.\",\n      \"evidence\": \"Isoform co-expression and survival assays in primary sympathetic neurons\",\n      \"pmids\": [\"8978665\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of dominant-negative action not resolved\", \"Single lab\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Demonstrated in vivo that TrkB is required for presynaptic maturation and synaptogenesis, moving TrkB from in vitro signaling to organ-level neural circuit development.\",\n      \"evidence\": \"Knockout mouse analysis with tract tracing, EM, and immunocytochemistry\",\n      \"pmids\": [\"9736654\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cell-autonomous vs network effects not separated\", \"Did not link a specific signaling arm to the phenotype\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Genetically separated the PLC\\u03b3 and Shc docking pathways, assigning hippocampal LTP/CaMKIV/CREB to PLC\\u03b3 and MAPK activation to Shc, establishing parallel TrkB signaling routes with distinct functions.\",\n      \"evidence\": \"Docking-site knockin mice with LTP electrophysiology and BDNF-stimulated signaling assays\",\n      \"pmids\": [\"12367511\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"PI3K arm not addressed in this design\", \"Behavioral consequences not fully mapped\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Showed TrkB/PI3K-Akt suppresses anoikis and drives metastasis, extending TrkB survival signaling to non-neural epithelial and oncogenic contexts.\",\n      \"evidence\": \"Genome-wide anoikis-suppression screen with pathway inhibition and mouse metastasis model\",\n      \"pmids\": [\"15329723\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Ligand dependence in tumors not fully defined\", \"Did not address isoform contributions\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Established a peripheral reproductive role for TrkB in ovarian follicle assembly via induction of FSH receptor, broadening TrkB function beyond the nervous system.\",\n      \"evidence\": \"Ntrk2 knockout mouse follicle counts, FSHR expression, NT-4 treatment\",\n      \"pmids\": [\"19357131\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Downstream signaling to FSHR not defined\", \"Single lab\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Defined excitotoxic regulation of TrkB by calpain cleavage and TrkB-T1 upregulation, and a ligand-trafficking control by TrkB-Shc, mechanistically linking isoform balance to neuronal death.\",\n      \"evidence\": \"Calpain cleavage and lentiviral rescue in neurons (22258407); overexpression immunoblots in CHOK1 cells (22425982)\",\n      \"pmids\": [\"22258407\", \"22425982\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"TrkB-Shc work limited to overexpression in non-neuronal cells, single method\", \"Endogenous relevance of the degradation mechanism unconfirmed\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Extended TrkB function to oligodendrocyte myelination and identified RAR\\u03b1 as a transcriptional activator of the TrkB promoter, addressing how TrkB output and expression are regulated.\",\n      \"evidence\": \"Oligodendrocyte-specific conditional knockout with EM/myelin readouts (23486965); promoter transactivation/ChIP assay (23960204)\",\n      \"pmids\": [\"23486965\", \"23960204\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"RAR\\u03b1 finding is single-lab, single-method, not replicated\", \"Signaling arm mediating myelination not pinpointed\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Showed gonadotropin-induced oocyte NTRK2.FL-AKT signaling is required for oocyte survival, with cooperative BDNF/kisspeptin input via NTRK2.T1 and KISS1R, defining a reproductive survival pathway.\",\n      \"evidence\": \"Oocyte-specific Ntrk2 knockout, gonadotropin stimulation, PI3K-AKT assays, cell-line co-expression\",\n      \"pmids\": [\"24877631\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of NTRK2.T1/KISS1R cooperativity not structurally defined\", \"Single lab\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Resolved post-translational control of TrkB trafficking: Slitrk5 directs ligand-dependent recycling via Rab11, while truncated TrkB-T1 drives glycine transporter internalization through Rho-GTPase, expanding the non-kinase roles of TrkB.\",\n      \"evidence\": \"Reciprocal Co-IP, super-resolution imaging, recycling assays, Slitrk5 KO (26004511); glycine transport, pharmacology and RNAi in astrocytes (26200505)\",\n      \"pmids\": [\"26004511\", \"26200505\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Glycine transporter work is single lab\", \"How TrkB-T1 engages Rho-GTPase mechanistically not resolved\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Demonstrated TrkB kinase activity sustains neuromuscular junction presynaptic terminals, particularly with aging, linking kinase function to peripheral synapse maintenance.\",\n      \"evidence\": \"Chemical-genetic kinase inhibition (TrkBF616A + 1NMPP1) with NMJ morphometry\",\n      \"pmids\": [\"26517952\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Downstream effectors at NMJ not identified\", \"Single lab\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Identified TrkB signaling within oxytocin neurons as a developmental driver of oxytocin expression and maternal behavior, embedding TrkB in social/behavioral circuits.\",\n      \"evidence\": \"OXT-neuron-specific TrkB conditional knockout with behavioral and TRAP RNA-seq readouts\",\n      \"pmids\": [\"30192229\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Signaling arm mediating oxytocin regulation not defined\", \"Single lab\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Showed corticostriatal TrkB-ERK signaling is required to balance goal-directed versus habitual behaviors, mapping TrkB kinase output onto defined action-selection circuits.\",\n      \"evidence\": \"Region-specific truncated TrkB overexpression with phospho-ERK assays and operant behavior\",\n      \"pmids\": [\"29540698\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Dominant-negative overexpression may have off-target effects\", \"Single lab\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Used spatial optogenetic activation to show local TrkB signaling initiates actin waves and specifies axonal identity, revealing a cell-biological role in neuronal polarization.\",\n      \"evidence\": \"Opto-cytTrkB activation with live actin imaging, Rac1 assays, ankyrinG staining\",\n      \"pmids\": [\"31678045\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Endogenous spatial ligand cues not addressed\", \"Single lab\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Established TrkB as a key node in PVH appetite circuits and showed truncated TrkB.T1 can drive ligand-independent glioma growth, linking TrkB to opposite physiological and pathological survival contexts.\",\n      \"evidence\": \"PVH-specific conditional knockout with chemogenetics/circuit tracing (32265438); PDGF glioma model with Akt/STAT3 assays (32532995)\",\n      \"pmids\": [\"32265438\", \"32532995\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of TrkB.T1 ligand-independent signaling not fully defined\", \"Glioma study single lab/Medium confidence\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Discovered antidepressants directly bind the TrkB transmembrane domain to potentiate BDNF signaling in a cholesterol-sensitive manner, and that postsynaptic CA1 TrkB mediates ketamine's rapid action, redefining TrkB as a direct drug target.\",\n      \"evidence\": \"MD simulations, binding assays, TMD-motif mutagenesis, in vivo behavior (33606976); CA1/CA3-specific deletion with electrophysiology and dynamin1 dependence (34407417)\",\n      \"pmids\": [\"33606976\", \"34407417\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural validation of the TMD binding pocket beyond simulation incomplete\", \"Generality across antidepressant classes not exhaustively mapped\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Showed adult TrkB signaling maintains prefrontal parvalbumin interneuron integrity and \\u03b3 oscillations, assigning TrkB a continuous role in mature inhibitory network function.\",\n      \"evidence\": \"Viral dominant-negative trkB in mPFC PV interneurons with LFP recording and behavior\",\n      \"pmids\": [\"33593856\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Dominant-negative may affect related receptors\", \"Single lab\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Extended TrkB's reach to senescent-cell survival (autocrine BDNF\\u2192ERK5/BCL2L2), oxytocin GPCR transactivation of TrkB at inhibitory synapses, and bone homeostasis, demonstrating broad TrkB signaling versatility.\",\n      \"evidence\": \"Drug screen + ERK5/BCL2L2 assays in aged mice (36266274); phospho-TrkB assays with oxytocin pharmacology (35721318); TrkB agonist/AEP KO/OVX bone models (35973996)\",\n      \"pmids\": [\"36266274\", \"35721318\", \"35973996\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Oxytocin and bone findings each single lab\", \"Cross-talk mechanism of GPCR transactivation not structurally defined\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Showed psychedelics (LSD, psilocin) bind TrkB with ~1000-fold higher affinity than antidepressants at a partially overlapping TMD site, and that their plasticity/antidepressant effects are TrkB-dependent but 5-HT2A-independent, dissociating two drug-receptor axes.\",\n      \"evidence\": \"Radioligand binding, MD simulations, TMD mutagenesis, and in vivo behavioral assays separating TrkB from 5-HT2A\",\n      \"pmids\": [\"37280397\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Co-crystal structure of psychedelic-bound TrkB not reported\", \"Relationship to clinical efficacy untested\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Linked cortical BDNF-TrkB-CREB signaling in layer 5 neurons to sleep slow-wave activity, placing TrkB synaptic-strength control upstream of a defined sleep electrophysiological output.\",\n      \"evidence\": \"Pharmacology/optogenetics with EEG, transcriptomics and proteomics in layer 5 neurons\",\n      \"pmids\": [\"39046880\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanistic role of the enriched ubiquitin/proteasome subunits not established\", \"Single lab\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How distinct extracellular vs transmembrane binding modes (neurotrophins, RNA aptamer C4-3, antidepressants, psychedelics, GPCR transactivation) are integrated into graded, context-specific TrkB output across diverse cell types remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified structural model coupling TMD allostery to kinase activation\", \"Cell-type determinants of isoform ratio and signaling-arm selection not defined\", \"How non-neuronal TrkB roles (bone, senescence, ovary, tumor) are gated remains open\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 1, 2, 5, 29]},\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"GO:0048018\", \"supporting_discovery_ids\": [1, 2]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [1, 30]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [3, 9]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 18, 13]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [13]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [2, 5, 6]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [4, 5, 17, 19]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [4, 10, 15]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [6, 8, 20]},\n      {\"term_id\": \"R-HSA-1474165\", \"supporting_discovery_ids\": [7, 12]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [6, 16, 20]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"BDNF\", \"NTF4\", \"SLITRK5\", \"KISS1R\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}